BeiGene Ownership 2024 | Who Owns BeiGene Now?


OverviewForecastRevenueFinancialsChart

Institutional Ownership

34.47%

Insider Ownership

19.54%

Retail Ownership

45.99%

Institutional Holders

199.00

BeiGene Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP7.80%19.27%10,568,897--1,507,864,535Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS5.17%0.21%7,013,568-50,860-0.72%1,002,125,786Jun 30, 2024
HHLR ADVISORS, LTD.3.82%18.22%5,176,906--738,589,179Jun 30, 2024
PRIMECAP MANAGEMENT CO/CA/3.68%0.52%4,986,289-15,550-0.31%711,393,852Jun 30, 2024
BAILLIE GIFFORD & CO2.72%0.41%3,681,949-46,781-1.25%525,303,663Jun 30, 2024
TEMASEK HOLDINGS (PRIVATE) LTD2.22%2.00%3,014,171--430,031,777Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.68%0.04%2,272,822246,72812.18%324,264,000Jun 30, 2024
FMR LLC1.22%0.01%1,647,156-33,307-1.98%234,999,813Jun 30, 2024
BLACKROCK INC.0.71%0.00%959,19210,5251.11%136,847,924Jun 30, 2024
CAPITAL INTERNATIONAL, INC./CA/0.63%1.62%855,134-3,230-0.38%122,001,968Jun 30, 2024
BOXER CAPITAL, LLC0.37%3.76%500,000--71,335,000Jun 30, 2024
POINT72 ASSET MANAGEMENT, L.P.0.28%0.14%381,382381,382100.00%54,411,770Jun 30, 2024
PUBLIC INVESTMENT FUND0.26%0.24%354,385--50,560,108Jun 30, 2024
VESTAL POINT CAPITAL, LP0.26%3.72%350,00025,0007.69%49,934,500Jun 30, 2024
ARTAL GROUP S.A.0.22%1.10%303,369-101,413-25.05%43,281,655Jun 30, 2024
BANK OF AMERICA CORP /DE/0.21%0.00%287,349-65,753-18.62%40,996,082Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.19%0.08%262,11011,2434.48%37,395,233Jun 30, 2024
FIRST TRUST ADVISORS LP0.18%0.04%250,35128,52012.86%35,717,577Jun 30, 2024
ARTISAN PARTNERS LIMITED PARTNERSHIP0.15%0.04%208,41863,48843.81%29,734,996Jun 30, 2024
CAPITAL GROUP PRIVATE CLIENT SERVICES, INC.0.14%0.28%192,840-15,960-7.64%27,512,483Jun 30, 2024

BeiGene's largest institutional shareholder is BAKER BROS. ADVISORS LP, holding 7.80% of the company's total share outstanding, currently valued at $1.51B. The top 10 institutional shareholders own together 29.64% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP7.80%19.27%10,568,897--1,507,864,535Jun 30, 2024
HHLR ADVISORS, LTD.3.82%18.22%5,176,906--738,589,179Jun 30, 2024
LONG CORRIDOR ASSET MANAGEMENT LTD0.04%7.11%52,62342,577423.82%7,507,723Jun 30, 2024
BOXER CAPITAL, LLC0.37%3.76%500,000--71,335,000Jun 30, 2024
VESTAL POINT CAPITAL, LP0.26%3.72%350,00025,0007.69%49,934,500Jun 30, 2024
NAN FUNG GROUP HOLDINGS LTD0.02%3.50%23,022--3,284,549Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.01%2.25%12,50812,508100.00%1,784,516Jun 30, 2024
TEMASEK HOLDINGS (PRIVATE) LTD2.22%2.00%3,014,171--430,031,777Jun 30, 2024
JGP GLOBAL GESTAO DE RECURSOS LTDA.0.01%1.90%10,464-7-0.07%1,492,899Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.08%1.81%110,00027,85733.91%15,693,700Jun 30, 2024
SOLEUS CAPITAL MANAGEMENT, L.P.0.10%1.73%137,700-10,400-7.02%19,645,659Jun 30, 2024
OLD WELL PARTNERS, LLC0.01%1.63%10,438-7,600-42.13%1,489,189Jun 30, 2024
CAPITAL INTERNATIONAL, INC./CA/0.63%1.62%855,134-3,230-0.38%122,001,968Jun 30, 2024
ALPHACENTRIC ADVISORS LLC0.01%1.58%15,000-1,750-10.45%2,140,050Jun 30, 2024
ARTAL GROUP S.A.0.22%1.10%303,369-101,413-25.05%43,281,655Jun 30, 2024
CAPITAL INTERNATIONAL SARL0.14%0.84%192,4254830.25%27,453,275Jun 30, 2024
TANG CAPITAL MANAGEMENT LLC0.03%0.54%37,000--5,278,790Jun 30, 2024
PRIMECAP MANAGEMENT CO/CA/3.68%0.52%4,986,289-15,550-0.31%711,393,852Jun 30, 2024
CAPITAL GROUP INVESTMENT MANAGEMENT PTE. LTD.0.01%0.49%16,030--2,287,000Jun 30, 2024
CAPITAL INTERNATIONAL LTD /CA/0.06%0.49%74,692-182-0.24%10,656,308Jun 30, 2024

The largest BeiGene shareholder by % of total assets is BAKER BROS. ADVISORS LP. The company owns 10.57M shares of BeiGene (BGNE), representing 19.27% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.0.28%0.14%381,382381,382100.00%54,411,770Jun 30, 2024
PRICE T ROWE ASSOCIATES INC /MD/1.68%0.04%2,272,822246,72812.18%324,264,000Jun 30, 2024
ARTISAN PARTNERS LIMITED PARTNERSHIP0.15%0.04%208,41863,48843.81%29,734,996Jun 30, 2024
WOODLINE PARTNERS LP0.03%0.06%45,07845,078100.00%6,431,278Jun 30, 2024
LONG CORRIDOR ASSET MANAGEMENT LTD0.04%7.11%52,62342,577423.82%7,507,723Jun 30, 2024
BARCLAYS PLC0.02%0.00%30,00030,000100.00%4,280,000Jun 30, 2024
FIRST TRUST ADVISORS LP0.18%0.04%250,35128,52012.86%35,717,577Jun 30, 2024
AFFINITY ASSET ADVISORS, LLC0.08%1.81%110,00027,85733.91%15,693,700Jun 30, 2024
VESTAL POINT CAPITAL, LP0.26%3.72%350,00025,0007.69%49,934,500Jun 30, 2024
GOLDMAN SACHS GROUP INC0.06%0.00%81,12622,74138.95%11,574,282Jun 30, 2024
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD.0.06%0.05%86,87621,26032.40%12,394,599Jun 30, 2024
BARINGS LLC0.04%0.18%51,76320,66366.44%7,385,027Jun 30, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP0.03%0.03%35,27517,10494.13%5,033,000Jun 30, 2024
WALLEYE CAPITAL LLC0.01%0.00%15,09713,624924.92%2,153,889Jun 30, 2024
GMT CAPITAL CORP0.01%0.07%13,62213,622100.00%1,943,451Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.01%2.25%12,50812,508100.00%1,784,516Jun 30, 2024
PARTNERS CAPITAL INVESTMENT GROUP, LLP0.01%0.03%12,37912,379100.00%1,766,112Jun 30, 2024
LEGAL & GENERAL GROUP PLC0.07%0.00%88,86012,29716.06%12,677,738Jun 30, 2024
ABRDN PLC0.02%0.01%33,06811,93056.44%4,717,812Jun 30, 2024
BAIRD FINANCIAL GROUP, INC.0.19%0.08%262,11011,2434.48%37,395,233Jun 30, 2024

As of Jun 30 2024, BeiGene's largest institutional buyer is POINT72 ASSET MANAGEMENT, L.P.. The company purchased 381.38K stocks of BGNE, valued at $54.41M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
ARTAL GROUP S.A.0.22%1.10%303,369-101,413-25.05%43,281,655Jun 30, 2024
INVESCO LTD.0.08%0.00%111,309-94,849-46.01%15,880,455Jun 30, 2024
BANK OF AMERICA CORP /DE/0.21%0.00%287,349-65,753-18.62%40,996,082Jun 30, 2024
PICTET ASSET MANAGEMENT HOLDING SA0.08%0.02%108,831-55,493-33.77%15,526,919Jun 30, 2024
MARSHALL WACE, LLP0.04%0.01%51,987-52,428-50.21%7,416,984Jun 30, 2024
CAPITAL INTERNATIONAL INVESTORS5.17%0.21%7,013,568-50,860-0.72%1,002,125,786Jun 30, 2024
BAILLIE GIFFORD & CO2.72%0.41%3,681,949-46,781-1.25%525,303,663Jun 30, 2024
INTEGRAL HEALTH ASSET MANAGEMENT, LLC----40,000-100.00%-Jun 30, 2024
MORGAN STANLEY0.06%0.00%85,833-36,945-30.09%12,245,878Jun 30, 2024
EXOME ASSET MANAGEMENT LLC----36,800-100.00%-Jun 30, 2024
FMR LLC1.22%0.01%1,647,156-33,307-1.98%234,999,813Jun 30, 2024
XY CAPITAL LTD----29,616-100.00%-Jun 30, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.01%0.30%11,100-20,405-64.77%1,583,637Jun 30, 2024
LMR PARTNERS LLP----18,954-100.00%-Jun 30, 2024
CANADA PENSION PLAN INVESTMENT BOARD----17,000-100.00%-Jun 30, 2024
UBS GROUP AG0.01%0.00%12,086-16,561-57.81%1,724,311Jun 30, 2024
CAPITAL GROUP PRIVATE CLIENT SERVICES, INC.0.14%0.28%192,840-15,960-7.64%27,512,483Jun 30, 2024
PRIMECAP MANAGEMENT CO/CA/3.68%0.52%4,986,289-15,550-0.31%711,393,852Jun 30, 2024
HSBC HOLDINGS PLC0.02%0.00%24,181-14,013-36.69%3,448,337Jun 30, 2024
GREAT WEST LIFE ASSURANCE CO /CAN/0.01%0.00%17,018-11,286-39.87%2,431,000Jun 30, 2024

As of Jun 30 2024, BeiGene's biggest institutional seller is ARTAL GROUP S.A.. The company sold -0.10M shares of BGNE, valued at $43.28M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
POINT72 ASSET MANAGEMENT, L.P.0.28%0.14%381,382381,382100.00%54,411,770Jun 30, 2024
WOODLINE PARTNERS LP0.03%0.06%45,07845,078100.00%6,431,278Jun 30, 2024
GMT CAPITAL CORP0.01%0.07%13,62213,622100.00%1,943,451Jun 30, 2024
SUPERSTRING CAPITAL MANAGEMENT LP0.01%2.25%12,50812,508100.00%1,784,516Jun 30, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC0.01%0.01%8,1858,185100.00%1,167,754Jun 30, 2024
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD.0.00%0.00%4,9214,921100.00%702,079Jun 30, 2024
MIRAE ASSET GLOBAL INVESTMENTS CO., LTD.0.00%0.00%4,1734,173100.00%607,505Jun 30, 2024
ATRIA INVESTMENTS, INC0.00%0.00%2,5742,574100.00%367,231Jun 30, 2024
PEAK6 INVESTMENTS LLC0.00%0.00%2,0002,000100.00%285,340Jun 30, 2024
TWO SIGMA SECURITIES, LLC0.00%0.00%1,6601,660100.00%236,832Jun 30, 2024
COREBRIDGE FINANCIAL, INC.0.00%0.00%700700100.00%99,869Jun 30, 2024

BeiGene's largest new institutional shareholder by number of shares is POINT72 ASSET MANAGEMENT, L.P., purchased 381.38K shares, valued at $54.41M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
INTEGRAL HEALTH ASSET MANAGEMENT, LLC----40,000-100.00%-Jun 30, 2024
EXOME ASSET MANAGEMENT LLC----36,800-100.00%-Jun 30, 2024
XY CAPITAL LTD----29,616-100.00%-Jun 30, 2024
LMR PARTNERS LLP----18,954-100.00%-Jun 30, 2024
CANADA PENSION PLAN INVESTMENT BOARD----17,000-100.00%-Jun 30, 2024
POLYMER CAPITAL MANAGEMENT (HK) LTD----9,500-100.00%-Jun 30, 2024
JEFFERIES FINANCIAL GROUP INC.----8,043-100.00%-Jun 30, 2024
PINPOINT ASSET MANAGEMENT LTD----5,300-100.00%-Jun 30, 2024
Y-INTERCEPT (HONG KONG) LTD----5,299-100.00%-Jun 30, 2024
BALYASNY ASSET MANAGEMENT L.P.----5,120-100.00%-Jun 30, 2024
SIMPLEX TRADING, LLC----3,439-100.00%-Jun 30, 2024
QUBE RESEARCH & TECHNOLOGIES LTD----2,533-100.00%-Jun 30, 2024
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC----1,445-100.00%-Jun 30, 2024
QTRON INVESTMENTS LLC----1,378-100.00%-Jun 30, 2024
ENVESTNET PORTFOLIO SOLUTIONS, INC.----1,339-100.00%-Jun 30, 2024
AMERICAN INTERNATIONAL GROUP, INC.----700-100.00%-Jun 30, 2024
WALLEYE CAPITAL LLC----400-100.00%-Jun 30, 2024
TORONTO DOMINION BANK----333-100.00%-Jun 30, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC----45-100.00%-Jun 30, 2024
FEDERATION DES CAISSES DESJARDINS DU QUEBEC----10-100.00%-Jun 30, 2024
COLONIAL TRUST ADVISORS----9-100.00%-Jun 30, 2024
BELL INVESTMENT ADVISORS, INC----6-100.00%-Jun 30, 2024
MATHER GROUP, LLC.----4-100.00%-Jun 30, 2024
ADVISORNET FINANCIAL, INC----2-100.00%-Jun 30, 2024
FINANCIAL GRAVITY ASSET MANAGEMENT, INC.----1-100.00%-Jun 30, 2024

BeiGene's largest sold out institutional shareholder by shares sold is INTEGRAL HEALTH ASSET MANAGEMENT, LLC, sold -40.00K shares, valued at -, as of undefined.

BeiGene Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
CAPITAL GROUP EMERGING MARKETS TOTAL OPPORTUNITIES FUND29059.83%1,700--Jan 31, 2020
Clough Global Equity Fund0.38%23,810--Jan 31, 2024
Fiera Capital Series Trust0.31%6,250--Jun 30, 2023
T. Rowe Price Health Sciences Fund, Inc.0.19%636,54759,37910.29%Mar 31, 2024
PRIMECAP Odyssey Funds0.17%1,377,814-8,400-0.61%Jan 31, 2024
American Funds Global Insight Fund0.13%268,09617,4386.96%Jan 31, 2024
Clough Global Opportunities Fund0.12%47,870--Jan 31, 2024
INVESCO BLDRS INDEX FUNDS TRUST0.11%6,3261,00818.95%Dec 31, 2022
NEW PERSPECTIVE FUND0.09%2,806,560318,19612.79%Mar 31, 2024
American Funds International Vantage Fund0.09%50,5385,02411.04%Jan 31, 2024
Tema ETF Trust0.06%2,479371.52%Feb 29, 2024
AMCAP FUND0.04%355,476--Feb 29, 2024
TEKLA LIFE SCIENCES INVESTORS0.04%16,838--Mar 31, 2024
TEKLA HEALTHCARE INVESTORS0.04%30,066--Mar 31, 2024
Clough Funds Trust0.03%1,410--Jan 31, 2023
T. Rowe Price Diversified Mid-Cap Growth Fund, Inc.0.03%11,70011,700-Mar 31, 2024
T. Rowe Price New Horizons Fund, Inc.0.03%144,000-74,700-34.16%Mar 31, 2024
BlackRock Health Sciences Trust0.03%6,675--Mar 31, 2024
FIDELITY MT VERNON STREET TRUST0.03%743,185-31,501-4.07%Feb 29, 2024
BlackRock Health Sciences Trust II0.03%68,555--Mar 31, 2024
VANGUARD SPECIALIZED FUNDS0.02%1,301,665--Jan 31, 2024
FIRST TRUST EXCHANGE-TRADED FUND0.02%220,5931,8340.84%Mar 31, 2024
Morgan Creek Global Equity Long/Short Institutional Fund0.02%415--Mar 31, 2024
T. Rowe Price Equity Series, Inc.0.02%30,4023,05611.18%Mar 31, 2024
T. Rowe Price International Series, Inc.0.02%8,1944315.55%Mar 31, 2024
REYNOLDS FUNDS INC0.02%200--Mar 31, 2024
EMERGING MARKETS GROWTH FUND INC0.02%245,434--Mar 31, 2024
AMERICAN FUNDS FUNDAMENTAL INVESTORS0.01%292,068--Mar 31, 2024
EUROPACIFIC GROWTH FUND0.01%1,053,59245,0124.46%Mar 31, 2024
GROWTH FUND OF AMERICA0.01%304,995--Feb 29, 2024
FIDELITY ADVISOR SERIES VIII0.01%158,292--Jan 31, 2024
T. Rowe Price Tax-Efficient Funds, Inc.0.01%900900-Feb 29, 2024
T. Rowe Price Small-Cap Stock Fund, Inc.0.01%27,664--Mar 31, 2024
AMERICAN FUNDS DEVELOPING WORLD GROWTH & INCOME FUND0.01%165,46816,09010.77%Feb 29, 2024
ALGER FUNDS0.01%5,775--Jan 31, 2024
CAPITAL GROUP PRIVATE CLIENT SERVICES FUNDS0.01%37,200--Jan 31, 2024
VARIABLE INSURANCE PRODUCTS FUND IV0.01%15,000--Mar 31, 2024
BAILLIE GIFFORD FUNDS0.01%57,691-2,455-4.08%Mar 28, 2024
FIDELITY ADVISOR SERIES VII0.01%43,928--Jan 31, 2024
VANGUARD HORIZON FUNDS0.01%120,521--Mar 31, 2024
AIM EQUITY FUNDS (INVESCO EQUITY FUNDS)0.00%51,660--Jan 31, 2024
FIDELITY COMMONWEALTH TRUST0.00%11,0621551.42%Feb 29, 2024
Tekla World Healthcare Fund0.00%4,114--Mar 31, 2024
DEUTSCHE DWS INTERNATIONAL FUND, INC.0.00%9,286--Feb 29, 2024
EntrepreneurShares Series Trust0.00%877-1,358-60.76%Dec 31, 2023
INTERNATIONAL GROWTH & INCOME FUND0.00%51,067-74-0.14%Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND III0.00%23,000--Mar 31, 2024
STATE STREET MASTER FUNDS0.00%9,200--Mar 31, 2024
VARIABLE INSURANCE PRODUCTS FUND II0.00%29,265--Mar 31, 2024
DELAWARE VIP TRUST0.00%8,002--Mar 28, 2024
BLACKROCK INDEX FUNDS, INC.0.00%15,242--Mar 31, 2024
FIDELITY SECURITIES FUND0.00%161,113--Jan 31, 2024
AIM SECTOR FUNDS (INVESCO SECTOR FUNDS)0.00%35,032--Jan 31, 2024
T. Rowe Price Equity Funds, Inc.0.00%17,634--Mar 31, 2024
Fidelity Commonwealth Trust II0.00%10,673--Aug 31, 2023
Innovator ETFs Trust0.00%6,226--Jan 31, 2024
STEWARD FUNDS, INC.0.00%3,2171655.41%Jan 31, 2024
MATTHEWS INTERNATIONAL FUNDS0.00%20,902--Mar 31, 2024
MSS Series Trust0.00%97--Feb 29, 2024
AIM INTERNATIONAL MUTUAL FUNDS (INVESCO INTERNATIONAL MUTUAL FUNDS)0.00%40,578-1,187-2.84%Jan 31, 2024
ETFis Series Trust I0.00%1,73928019.19%Jan 31, 2024
Krane Shares Trust0.00%20,558--Dec 31, 2023
BNY MELLON INDEX FUNDS, INC.0.00%1,485--Apr 30, 2022
Bernstein Fund Inc0.00%9,130--Mar 31, 2024
FIDELITY CAPITAL TRUST0.00%10,600--Jan 31, 2024
FIDELITY INVESTMENT TRUST0.00%169,830-82,662-32.74%Jan 31, 2024
Goldman Sachs ETF Trust II0.00%832567.22%Feb 29, 2024
John Hancock Exchange-Traded Fund Trust0.00%4,224-48-1.12%Jan 31, 2024
RYDEX VARIABLE TRUST0.00%703--Dec 31, 2023
FIDELITY PURITAN TRUST0.00%26,964--Jan 31, 2024
TOUCHSTONE STRATEGIC TRUST0.00%28,499--Mar 31, 2024
Delaware Enhanced Global Dividend & Income Fund0.00%158--Feb 28, 2023
SCHWAB CAPITAL TRUST0.00%17,904--Feb 29, 2024
VARIABLE INSURANCE PRODUCTS FUND0.00%8,500--Mar 31, 2024
AIM COUNSELOR SERIES TRUST (INVESCO COUNSELOR SERIES TRUST)0.00%91,818--Feb 29, 2024
FIRST TRUST EXCHANGE-TRADED FUND II0.00%2,680--Mar 31, 2024
HARBOR FUNDS0.00%8,056--Jan 31, 2024
Fidelity Central Investment Portfolios LLC0.00%17,345-4,363-20.10%Mar 31, 2024
VANGUARD STAR FUNDS0.00%542,388--Jan 31, 2024
T. Rowe Price Global Allocation Fund, Inc.0.00%474-3-0.63%Jan 31, 2024
VANGUARD INTERNATIONAL EQUITY INDEX FUNDS0.00%561,715--Jan 31, 2024
BLACKROCK ADVANTAGE GLOBAL FUND, INC.0.00%72--Mar 31, 2024
PFM Multi-Manager Series Trust0.00%200--Dec 31, 2023
BLACKROCK SUSTAINABLE BALANCED FUND, INC.0.00%1,704--Feb 29, 2024
DEUTSCHE DWS INSTITUTIONAL FUNDS0.00%73--Mar 31, 2024
OHIO NATIONAL FUND INC0.00%4,618--Mar 31, 2024
Brinker Capital Destinations Trust0.00%12,697-311-2.39%Feb 29, 2024
VICTORY PORTFOLIOS0.00%6,450--Mar 31, 2024
SCM Trust0.00%600--Dec 31, 2023
VANGUARD TRUSTEES' EQUITY FUND0.00%7,125--Jan 31, 2024
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%12,600--Mar 31, 2024
FundVantage Trust0.00%2,986--Mar 28, 2024
BlackRock ETF Trust0.00%17163.64%Jan 31, 2024
JPMORGAN TRUST IV0.00%4,145--Jan 31, 2024
BAIRD FUNDS INC0.00%197,45167,34551.76%Mar 31, 2024
PRAXIS MUTUAL FUNDS0.00%1,789--Dec 31, 2023
Listed Funds Trust0.00%730--Mar 31, 2024
Voya VARIABLE PORTFOLIOS INC0.00%4,677--Mar 31, 2024
FIDELITY SELECT PORTFOLIOS0.00%9,198-18,300-66.55%Feb 29, 2024
WILLIAM BLAIR FUNDS0.00%13,606--Mar 31, 2024

BeiGene's largest mutual fund holder by % of total assets is "CAPITAL GROUP EMERGING MARKETS TOTAL OPPORTUNITIES FUND", owning 1.70K shares, compromising 29059.83% of its total assets.

BeiGene Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
30 Jun, 24199-3.86%
31 Mar, 24207-0.96%
31 Dec, 232091.95%
30 Sep, 23205-3.76%
30 Jun, 23213-6.17%
31 Mar, 232273.18%
31 Dec, 222202.33%
30 Sep, 22215-6.93%
30 Jun, 22231-6.10%
31 Mar, 22246-9.23%
31 Dec, 212714.63%
30 Sep, 21259-3.72%
30 Jun, 212693.46%
31 Mar, 212601.56%
31 Dec, 202560.79%
30 Sep, 2025413.39%
30 Jun, 202243.23%
31 Mar, 20217-9.58%
31 Dec, 1924014.83%
30 Sep, 192090.48%
30 Jun, 192080.48%
31 Mar, 192071.97%
31 Dec, 1820331.82%
30 Sep, 1815410.79%
30 Jun, 181394.51%
31 Mar, 1813333.00%
31 Dec, 1710013.64%
30 Sep, 178851.72%
30 Jun, 17585.45%
31 Mar, 17551.85%
31 Dec, 165442.11%
30 Sep, 1638-5.00%
30 Jun, 1640-
31 Mar, 1640-

As of 30 Jun 24, 199 institutions are holding BeiGene's shares, representing a decrease of -3.86% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
30 Jun, 2446,721,8710.69%
31 Mar, 2446,399,4933.32%
31 Dec, 2344,906,761-4.78%
30 Sep, 2347,161,4730.33%
30 Jun, 2347,007,959-1.41%
31 Mar, 2347,682,464-3.44%
31 Dec, 2249,381,063-7.63%
30 Sep, 2253,457,246-0.12%
30 Jun, 2253,521,949-2.66%
31 Mar, 2254,981,907-0.85%
31 Dec, 2155,453,245-1.71%
30 Sep, 2156,415,1821.15%
30 Jun, 2155,774,990-1.81%
31 Mar, 2156,801,7693.86%
31 Dec, 2054,688,785-0.77%
30 Sep, 2055,115,6999.11%
30 Jun, 2050,513,8132.40%
31 Mar, 2049,327,8600.32%
31 Dec, 1949,168,181-1.92%
30 Sep, 1950,130,2801.53%
30 Jun, 1949,376,3840.65%
31 Mar, 1949,057,7502.91%
31 Dec, 1847,672,5713.83%
30 Sep, 1845,914,3828.65%
30 Jun, 1842,260,00215.93%
31 Mar, 1836,452,88432.23%
31 Dec, 1727,567,0069.43%
30 Sep, 1725,192,36223.41%
30 Jun, 1720,413,49815.94%
31 Mar, 1717,607,6206.04%
31 Dec, 1616,604,41963.41%
30 Sep, 1610,161,00722.78%
30 Jun, 168,275,6147.17%
31 Mar, 167,721,902-

BeiGene (BGNE) has 46.72M shares outstanding as of 30 Jun 24, up 0.69% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
30 Jun, 2434.47%1.74%
31 Mar, 2444.45%4.08%
31 Dec, 2333.00%1.62%
30 Sep, 2345.07%2.21%
30 Jun, 2345.13%2.15%
31 Mar, 2345.78%2.00%
31 Dec, 2247.88%1.79%
30 Sep, 2251.66%1.91%
30 Jun, 2252.06%1.81%
31 Mar, 2253.66%1.50%
31 Dec, 2159.77%1.62%
30 Sep, 2160.81%1.65%
30 Jun, 2160.72%1.57%
31 Mar, 2162.11%1.71%
31 Dec, 2060.20%1.55%
30 Sep, 2062.36%1.48%
30 Jun, 2065.00%1.60%
31 Mar, 2063.79%0.95%
31 Dec, 1981.87%1.18%
30 Sep, 1983.39%1.22%
30 Jun, 1982.56%1.22%
31 Mar, 1982.32%1.11%
31 Dec, 1885.99%1.32%
30 Sep, 1880.68%1.30%
30 Jun, 1878.65%1.57%
31 Mar, 1870.68%1.93%
31 Dec, 1760.53%1.69%
30 Sep, 1759.81%2.28%
30 Jun, 1751.26%2.61%
31 Mar, 1744.32%2.53%
31 Dec, 1641.85%4.40%
30 Sep, 1630.85%4.88%
30 Jun, 1625.15%2.16%
31 Mar, 1634.14%-

As of 30 Jun 24, BeiGene is held by 34.47% institutional shareholders, representing a 1.74% growth compared to 31 Mar 24.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
30 Jun, 2488-31.25%
31 Mar, 2412837.63%
31 Dec, 23935.68%
30 Sep, 2388-2.22%
30 Jun, 2390-18.18%
31 Mar, 231104.76%
31 Dec, 221059.38%
30 Sep, 2296-14.29%
30 Jun, 22112-5.88%
31 Mar, 22119-7.03%
31 Dec, 21128-0.78%
30 Sep, 21129-7.86%
30 Jun, 211402.94%
31 Mar, 21136-2.86%
31 Dec, 20140-9.68%
30 Sep, 2015523.02%
30 Jun, 201265.88%
31 Mar, 20119-
31 Dec, 191198.18%
30 Sep, 19110-8.33%
30 Jun, 1912015.38%
31 Mar, 19104-26.76%
31 Dec, 1814257.78%
30 Sep, 189036.36%
30 Jun, 1866-25.00%
31 Mar, 188857.14%
31 Dec, 1756-12.50%
30 Sep, 176482.86%
30 Jun, 17359.38%
31 Mar, 1732-27.27%
31 Dec, 1644175.00%
30 Sep, 1616-15.79%
30 Jun, 1619-52.50%
31 Mar, 1640-

88 institutional shareholders have increased their position in BGNE stock as of 30 Jun 24 compared to 128 in the previous quarter (a -31.25% decrease).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
30 Jun, 246336.96%
31 Mar, 2446-37.84%
31 Dec, 23747.25%
30 Sep, 2369-2.82%
30 Jun, 237112.70%
31 Mar, 2363-17.11%
31 Dec, 2276-
30 Sep, 2276-2.56%
30 Jun, 2278-
31 Mar, 2278-13.33%
31 Dec, 219020.00%
30 Sep, 2175-5.06%
30 Jun, 2179-7.06%
31 Mar, 2185-
31 Dec, 208554.55%
30 Sep, 2055-15.38%
30 Jun, 2065-
31 Mar, 2065-18.75%
31 Dec, 198050.94%
30 Sep, 19536.00%
30 Jun, 1950-9.09%
31 Mar, 195561.76%
31 Dec, 1834-8.11%
30 Sep, 1837-27.45%
30 Jun, 185137.84%
31 Mar, 183732.14%
31 Dec, 1728100.00%
30 Sep, 1714-17.65%
30 Jun, 171754.55%
31 Mar, 1711266.67%
31 Dec, 163-57.14%
30 Sep, 16740.00%
30 Jun, 165-
31 Mar, 16--

63 institutional shareholders have reduced their position in BGNE stock as of 30 Jun 24 compared to 46 in the previous quarter (a 36.96% increase).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
30 Jun, 24199-3.86%46,721,8710.69%34.47%1.74%88-31.25%6336.96%
31 Mar, 24207-0.96%46,399,4933.32%44.45%4.08%12837.63%46-37.84%
31 Dec, 232091.95%44,906,761-4.78%33.00%1.62%935.68%747.25%
30 Sep, 23205-3.76%47,161,4730.33%45.07%2.21%88-2.22%69-2.82%
30 Jun, 23213-6.17%47,007,959-1.41%45.13%2.15%90-18.18%7112.70%
31 Mar, 232273.18%47,682,464-3.44%45.78%2.00%1104.76%63-17.11%
31 Dec, 222202.33%49,381,063-7.63%47.88%1.79%1059.38%76-
30 Sep, 22215-6.93%53,457,246-0.12%51.66%1.91%96-14.29%76-2.56%
30 Jun, 22231-6.10%53,521,949-2.66%52.06%1.81%112-5.88%78-
31 Mar, 22246-9.23%54,981,907-0.85%53.66%1.50%119-7.03%78-13.33%
31 Dec, 212714.63%55,453,245-1.71%59.77%1.62%128-0.78%9020.00%
30 Sep, 21259-3.72%56,415,1821.15%60.81%1.65%129-7.86%75-5.06%
30 Jun, 212693.46%55,774,990-1.81%60.72%1.57%1402.94%79-7.06%
31 Mar, 212601.56%56,801,7693.86%62.11%1.71%136-2.86%85-
31 Dec, 202560.79%54,688,785-0.77%60.20%1.55%140-9.68%8554.55%
30 Sep, 2025413.39%55,115,6999.11%62.36%1.48%15523.02%55-15.38%
30 Jun, 202243.23%50,513,8132.40%65.00%1.60%1265.88%65-
31 Mar, 20217-9.58%49,327,8600.32%63.79%0.95%119-65-18.75%
31 Dec, 1924014.83%49,168,181-1.92%81.87%1.18%1198.18%8050.94%
30 Sep, 192090.48%50,130,2801.53%83.39%1.22%110-8.33%536.00%
30 Jun, 192080.48%49,376,3840.65%82.56%1.22%12015.38%50-9.09%
31 Mar, 192071.97%49,057,7502.91%82.32%1.11%104-26.76%5561.76%
31 Dec, 1820331.82%47,672,5713.83%85.99%1.32%14257.78%34-8.11%
30 Sep, 1815410.79%45,914,3828.65%80.68%1.30%9036.36%37-27.45%
30 Jun, 181394.51%42,260,00215.93%78.65%1.57%66-25.00%5137.84%
31 Mar, 1813333.00%36,452,88432.23%70.68%1.93%8857.14%3732.14%
31 Dec, 1710013.64%27,567,0069.43%60.53%1.69%56-12.50%28100.00%
30 Sep, 178851.72%25,192,36223.41%59.81%2.28%6482.86%14-17.65%
30 Jun, 17585.45%20,413,49815.94%51.26%2.61%359.38%1754.55%
31 Mar, 17551.85%17,607,6206.04%44.32%2.53%32-27.27%11266.67%
31 Dec, 165442.11%16,604,41963.41%41.85%4.40%44175.00%3-57.14%
30 Sep, 1638-5.00%10,161,00722.78%30.85%4.88%16-15.79%740.00%
30 Jun, 1640-8,275,6147.17%25.15%2.16%19-52.50%5-
31 Mar, 1640-7,721,902-34.14%-40---

BeiGene Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 01, 2024Lee Chan Henryofficer SVP, General CounselS-SaleSell834$160.57$133.92K-
Jul 03, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell472$143.90$67.92K-
Jun 26, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell899$155.66$139.94K-
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell1,062$159.80$169.71K2
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell2$161.10$322.20-
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell1,036$159.53$165.27K423
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell400$160.38$64.15K23
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell23$161.27$3.71K-
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell2,389$159.49$381.02K400
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell400$160.12$64.05K-
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell297$158.53$47.08K984
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell608$159.40$96.91K376
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell376$159.91$60.13K-
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell154$158.24$24.37K762
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell195$158.58$30.92K567
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell253$159.00$40.23K314

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Wang Xiaodongdirector, other Chair, Scientific Advisory BrdG-GiftSell301,457--5,266,973
Aug 01, 2024Lee Chan Henryofficer SVP, General CounselS-SaleSell834$160.57$133.92K-
Jul 03, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell472$143.90$67.92K-
Jun 26, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell899$155.66$139.94K-
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell1,062$159.80$169.71K2
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell2$161.10$322.20-
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell1,036$159.53$165.27K423
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell400$160.38$64.15K23
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell23$161.27$3.71K-
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell2,389$159.49$381.02K400
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell400$160.12$64.05K-
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell297$158.53$47.08K984
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell608$159.40$96.91K376
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell376$159.91$60.13K-
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell154$158.24$24.37K762
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell195$158.58$30.92K567
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell253$159.00$40.23K314

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Aug 14, 2024Wang Xiaodongdirector, other Chair, Scientific Advisory BrdG-GiftSell301,457--5,266,973
Aug 13, 2024Rosenberg Aaronofficer Chief Financial OfficerA-AwardBuy220,987$14.06$3.11M220,987
Aug 13, 2024Rosenberg Aaronofficer Chief Financial OfficerA-AwardBuy118,547--118,547
Aug 01, 2024Lee Chan Henryofficer SVP, General CounselS-SaleSell834$160.57$133.92K-
Jul 24, 2024Rosenberg Aaronofficer-Buy----
Jul 03, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell472$143.90$67.92K-
Jun 26, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell899$155.66$139.94K-
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell1,062$159.80$169.71K2
Jun 26, 2024Wang Laiofficer Global Head of R&DS-SaleSell2$161.10$322.20-
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell1,036$159.53$165.27K423
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell400$160.38$64.15K23
Jun 26, 2024Wu Xiaobinofficer President, COO & GM ChinaS-SaleSell23$161.27$3.71K-
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell2,389$159.49$381.02K400
Jun 26, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell400$160.12$64.05K-
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell297$158.53$47.08K984
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell608$159.40$96.91K376
Jun 20, 2024OYLER JOHNdirector, officer Chief Executive OfficerS-SaleSell376$159.91$60.13K-
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell154$158.24$24.37K762
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell195$158.58$30.92K567
Jun 20, 2024Wang Julia Aijunofficer Chief Financial OfficerS-SaleSell253$159.00$40.23K314

The last insider sell of BeiGene's stock was made by Wang Xiaodong on Aug 14 2024, selling 301,457 shares at - per share (valued at -).

BeiGene Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 20242366.67%
Q2 2024313881.58%
Q1 20241185.56%
Q4 2023-4-
Q3 2023-2-
Q2 20232928103.57%
Q1 20231234.35%
Q4 2022-20-
Q3 20222385.26%
Q2 20222316143.75%
Q1 20223--
Q4 202187710.39%
Q3 202192084.33%
Q2 2021366258.06%
Q1 202153016.67%
Q4 2020125820.69%
Q3 2020192507.60%
Q2 2020196429.69%
Q1 202031127.27%
Q4 201995915.25%

2 total buy trades, and 3 total sell trades (buy/sell ratio of 0.67%) were made by BeiGene's insiders, as of Q3 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q3 2024-2-
Q2 2024-38-
Q1 2024-15-
Q4 2023-2-
Q3 2023-2-
Q2 2023-26-
Q1 2023-21-
Q4 2022-19-
Q3 2022-36-
Q2 2022-14-
Q1 2022---
Q4 2021-73-
Q3 202112030.49%
Q2 2021-44-
Q1 2021-24-
Q4 2020-46-
Q3 2020-240-
Q2 2020-57-
Q1 2020-8-
Q4 2019-54-

As of Q3 2024, Insider owners conducted 0 open market buy trades and 2 open market sell trades of BeiGene's stocks.

BeiGene Peer Ownership


TickerCompany
IONSIonis Pharmaceuticals, Inc.
INCYIncyte Corporation
ARWRArrowhead Pharmaceuticals, Inc.
AKROAkero Therapeutics, Inc.
APLSApellis Pharmaceuticals, Inc.
BPMCBlueprint Medicines Corporation
BMRNBioMarin Pharmaceutical Inc.
TVTXTravere Therapeutics, Inc.
LEGNLegend Biotech Corporation
RXDXPrometheus Biosciences, Inc.
ASNDAscendis Pharma A/S
KRYSKrystal Biotech, Inc.
IMVTImmunovant, Inc.
PCVXVaxcyte, Inc.
IMABI-Mab

BGNE Ownership FAQ


BeiGene is owned by institutional shareholders (34.47%), insiders (19.54%), and public (45.99%). The largest institutional shareholder of BeiGene is BAKER BROS. ADVISORS LP (7.80% of total shares) and the top mutual fund owner is CAPITAL GROUP EMERGING MARKETS TOTAL OPPORTUNITIES FUND (29059.83% of total shares).

BeiGene's major institutional shareholders are BAKER BROS. ADVISORS LP, CAPITAL INTERNATIONAL INVESTORS, HHLR ADVISORS, LTD., PRIMECAP MANAGEMENT CO/CA/, and BAILLIE GIFFORD & CO. The top five shareholders own together 23.18% of the company's share outstanding.

As of Jun 2024, there are 199 institutional shareholders of BeiGene.

BAKER BROS. ADVISORS LP owns 10.57M shares of BeiGene, representing 7.80% of the company's total shares outstanding, valued at $1.51B (as of Jun 2024).

As of Jun 2024, CAPITAL INTERNATIONAL INVESTORS holds 7.01M shares of BeiGene (BGNE), compromising 5.17% of the company, valued at $1B.

HHLR ADVISORS, LTD is the third largest holder of BeiGene. The company owns 5.18M of the company's shares outstanding (worth $738.59M).